Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma-Reference-Cited by-同舟云学术

Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma

Published:2018-11-22 Issue:21 Volume:132 Page:2273-2279
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Kobe Carsten¹,Goergen Helen²,Baues Christian³,Kuhnert Georg¹,Voltin Conrad-Amadeus¹^ORCID,Zijlstra Josée⁴,Hoekstra Otto⁵,Mettler Jasmin¹,Drzezga Alexander¹,Engert Andreas⁶,Borchmann Peter⁶,Dietlein Markus¹

Affiliation:

1. Department of Nuclear Medicine,

2. German Hodgkin Study Group (GHSG), Department I of Internal Medicine,

3. Department for Radiooncology and Cyberknife Center, University Hospital of Cologne, Cologne, Germany;

4. Department of Hematology, Cancer Center Amsterdam and

5. Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands; and

6. Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Abstract

Key Points DS4 is recommended as the cutoff value for PET-2 positivity after 2 cycles eBEACOPP for advanced-stage HL.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/132/21/2273/1467809/blood852129.pdf

Reference23 articles.

1. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma;Hutchings;Blood,2006

2. Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin’s lymphoma: a report from a joint Italian-Danish study;Gallamini;J Clin Oncol,2007

3. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group;Barrington;J Clin Oncol,2014

4. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification;Cheson;J Clin Oncol,2014

5. PET/CT for staging; past, present and future;El-Galaly;Semin Nucl Med,2018

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to treat advanced Hodgkin lymphoma?;Current Opinion in Oncology;2024-06-25

2. Is 18F-FDG-PET/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and Cons;Cancers;2024-05-24

3. Molecular biomarkers in classic Hodgkin lymphoma;Seminars in Hematology;2024-05

4. Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study;British Journal of Haematology;2024-04-29

5. Hodgkin-Lymphom;PET/CT-Atlas;2024